Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012883 |
---|---|
Receipt number | R000015039 |
Scientific Title | Multicenter Phase 1b/2 Trial of TAS-102 with Bevacizumab in Patients with Metastatic Colorectal Cancer (mCRC) who had the progression or intolerant to standard therapies. |
Date of disclosure of the study information | 2014/02/07 |
Last modified on | 2015/08/07 08:53:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/17 12:48:31 | ||
2 | Update | 2014/01/20 10:43:19 | Narrative objectives1 |
|
3 | Update | 2014/02/20 08:50:21 | Recruitment status Anticipated trial start date |
|
4 | Update | 2014/04/28 11:52:11 | UMIN ID1 |
|
5 | Update | 2014/05/16 10:05:46 | UMIN ID2 |
|
6 | Update | 2014/07/17 15:43:34 | Recruitment status |
|
7 | Update | 2015/04/13 13:46:52 | Organization Organization Organization Division name Institute Institutions |
|
8 | Update | 2015/06/16 14:57:16 | Publication of results |
|
9 | Update | 2015/06/16 14:59:42 | Other related information |
|
10 | Update | 2015/07/17 10:06:43 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2015/08/07 08:53:14 | Recruitment status Date of closure to data entry Date trial data considered complete |